Company Announcements

Publication of Final Terms

Source: RNS
RNS Number : 4192J
Bank of Nova Scotia
26 April 2022

Regulatory Announcement




Publication of Final Terms


Not for release, publication or distribution, directly or indirectly, in or into the United States.


The Bank of Nova Scotia has agreed to issue €118,000,000 1.806 per cent. Covered Bonds due 26 April 2037, Series CBL47, on 26 April 2022 (the "Covered Bonds") for the CDN$100,000,000,000 Global Registered Covered Bond Program of The Bank of Nova Scotia, unconditionally and irrevocably guaranteed as to payments of interest and principal by Scotiabank Covered Bond Guarantor Limited Partnership (the "Program")


The following document constitutes the Final Terms dated 22 April 2022 (the "Final Terms") relating to the issue of the Covered Bonds for purpose of Article 8 of Regulation (EU) 2017/1129 as it forms part of domestic law of the UK by virtue of the European Union (Withdrawal) Act 2018 and must be read in conjunction with the Prospectus dated 3 September 2021, as supplemented by the First Supplement dated 18 October 2021, the Second Supplement dated 7 December 2021 and the Third Supplement dated 1 March 2022 (together, the "Prospectus").  Full information on The Bank of Nova Scotia and the offer of the Covered Bonds is only available on the basis of the combination of the Final Terms and the Prospectus.


The Final Terms have been submitted to the National Storage Mechanism and will shortly be available for inspection at:




Please note that the information contained in the Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed.  Prior to relying on the information contained in the Prospectus and the Final Terms you must ascertain from the Prospectus, as supplemented by these Final Terms, whether or not you are part of the intended addressees of the information contained therein.


In particular, neither the Prospectus nor the Final Terms have been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state of the United States and may not be offered or sold, directly or indirectly, within the US or to or for the account or benefit of a "US person" (as defined in Regulation S under the Securities Act).  Accordingly, the Covered Bonds will be offered only in offshore transactions to non-US persons in reliance upon Regulation S under the Securities Act.  This announcement does not constitute an offer to sell or a solicitation to buy securities in the US or in any other jurisdiction where such offer or solicitation would be unlawful. 


Your right to access this service is conditional upon complying with the above requirement.


MiFID II professionals / ECPs-only / No PRIIPs KID - Manufacturer target market (MiFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in EEA and the UK.


To view the Final Terms, please paste the following URLs into the address bar of your browser.






For further information, please contact:


The Bank of Nova Scotia

Scotia Plaza

40 King Street West

Toronto, Ontario

Canada M5H 1H1


Attn: Managing Director, Term Funding & Capital Management

Tel.: 001 416 860 1784

Fax: 001 416 945 4001








This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.